GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dis-Chem Pharmacies Ltd (JSE:DCP) » Definitions » Debt-to-EBITDA

Dis-Chem Pharmacies (JSE:DCP) Debt-to-EBITDA : 2.72 (As of Aug. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Dis-Chem Pharmacies Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dis-Chem Pharmacies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was R1,624 Mil. Dis-Chem Pharmacies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Aug. 2023 was R3,359 Mil. Dis-Chem Pharmacies's annualized EBITDA for the quarter that ended in Aug. 2023 was R1,830 Mil. Dis-Chem Pharmacies's annualized Debt-to-EBITDA for the quarter that ended in Aug. 2023 was 2.72.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Dis-Chem Pharmacies's Debt-to-EBITDA or its related term are showing as below:

JSE:DCP' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.84   Med: 1.94   Max: 2.96
Current: 2.96

During the past 10 years, the highest Debt-to-EBITDA Ratio of Dis-Chem Pharmacies was 2.96. The lowest was 0.84. And the median was 1.94.

JSE:DCP's Debt-to-EBITDA is ranked worse than
52.69% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 2.58 vs JSE:DCP: 2.96

Dis-Chem Pharmacies Debt-to-EBITDA Historical Data

The historical data trend for Dis-Chem Pharmacies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dis-Chem Pharmacies Debt-to-EBITDA Chart

Dis-Chem Pharmacies Annual Data
Trend Feb14 Feb15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.08 2.00 2.25 1.87 1.78

Dis-Chem Pharmacies Semi-Annual Data
Feb14 Feb15 Aug15 Feb16 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.77 2.86 2.30 3.23 2.72

Competitive Comparison of Dis-Chem Pharmacies's Debt-to-EBITDA

For the Pharmaceutical Retailers subindustry, Dis-Chem Pharmacies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dis-Chem Pharmacies's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dis-Chem Pharmacies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Dis-Chem Pharmacies's Debt-to-EBITDA falls into.



Dis-Chem Pharmacies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Dis-Chem Pharmacies's Debt-to-EBITDA for the fiscal year that ended in Feb. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1812.072 + 3162.071) / 2789.279
=1.78

Dis-Chem Pharmacies's annualized Debt-to-EBITDA for the quarter that ended in Aug. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1623.931 + 3358.506) / 1829.558
=2.72

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Aug. 2023) EBITDA data.


Dis-Chem Pharmacies  (JSE:DCP) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Dis-Chem Pharmacies Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Dis-Chem Pharmacies's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Dis-Chem Pharmacies (JSE:DCP) Business Description

Traded in Other Exchanges
N/A
Address
23 Stag Road, Glen Austin, Midrand, Johannesburg, GT, ZAF, 1685
Dis-Chem Pharmacies Ltd is a pharmaceutical company based in South Africa. Its product portfolio includes personal care products, beauty products, healthcare and nutrition products, and dispensary and baby care products. The operating segments of the group are Retail and Wholesale. It derives maximum revenue from the Retail segment, which includes company stores, retailers of pharmaceutical and a variety of health and beauty products, as well as pharma-logistic services and oncology and retailers of pharmaceutical products. The Wholesale segment consists of the CJ wholesale and company distribution businesses, wholesalers of pharmaceuticals, and a variety of health and beauty products. Geographically, the group carries its business operations principally in South Africa.

Dis-Chem Pharmacies (JSE:DCP) Headlines